Rajesh Patel appointed as CEO of Trivitron Healthcare India IVD business

Published On 2020-07-07 08:05 GMT   |   Update On 2020-07-07 08:05 GMT

New Delhi: Medical technology firm Trivitron Healthcare on Monday announced the appointment of Rajesh Patel as Chief Executive Officer of its India in-vitro diagnostics (IVD) business. Patel has around 29 years of experience in the areas of sales, marketing, and business development in the healthcare segment. Trivitron Healthcare said in a statement.He has held leadership roles in global...

Login or Register to read the full article

New Delhi: Medical technology firm Trivitron Healthcare on Monday announced the appointment of Rajesh Patel as Chief Executive Officer of its India in-vitro diagnostics (IVD) business. Patel has around 29 years of experience in the areas of sales, marketing, and business development in the healthcare segment. Trivitron Healthcare said in a statement.

He has held leadership roles in global and Indian healthcare companies and has experience in pharmaceuticals, clinical research, and IVD/medical devices segment, it added.

"In his new role, Patel will be at the helm of the company's IVD business growth and expansion plans," Trivitron Healthcare Chairman and MD G S K Velu said.

Trivitron Healthcare has 13 manufacturing facilities in India, Finland, Turkey, and China that are the United States Food and Drug Administration (USFDA) and CE certified. It distributes medical technology products to 180 countries.

Read also: VB Gopal Krishnan appointed as Neuberg Diagnostics Group CFO


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News